- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/62 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving urea
Patent holdings for IPC class G01N 33/62
Total number of patents in this class: 89
10-year publication summary
14
|
12
|
5
|
7
|
7
|
5
|
8
|
2
|
5
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Labrador Diagnostics LLC | 282 |
9 |
Roche Diagnostics Operations, Inc. | 1436 |
3 |
Church & Dwight Co., Inc. | 1876 |
3 |
Arizona Board of Regents on behalf of Arizona State University | 2471 |
3 |
The Regents of the University of California | 19544 |
2 |
Ajinomoto Co., Inc. | 2319 |
2 |
Agency for Science, Technology and Research | 3563 |
2 |
Duke University | 3012 |
2 |
Aurinia Pharmaceuticals Inc. | 80 |
2 |
Dignity Health | 461 |
2 |
Metanomics GmbH | 20 |
2 |
Radiometer Medical ApS | 177 |
2 |
Sierra Molecular Corporation | 5 |
2 |
Okayama Prefecture Industrial Promotion Foundation | 5 |
2 |
Infagen (Hong Kong) Limited | 2 |
2 |
The Procter & Gamble Company | 22147 |
1 |
Samsung Electronics Co., Ltd. | 139302 |
1 |
F. Hoffmann-La Roche AG | 7951 |
1 |
Roche Diagnostics GmbH | 2696 |
1 |
Abbott Point Of Care Inc. | 319 |
1 |
Other owners | 44 |